A trial of additional treatment for oesophageal cancer and stomach cancer (PLATFORM)

Overview

Cancer types:

Oesophageal cancer, Secondary cancers, Stomach cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at giving more treatment after the first treatment for oesophageal cancer and stomach cancer. It was for people whose cancer couldn’t be removed with surgery. They had cancer of the:

  • food pipe (oesophageal cancer)

  • stomach (gastric cancer)

  • area where the food pipe meets the stomach (gastro oesophageal junction cancer)

People could join the trial between 2015 and 2024. The team published several papers in medical journals and presented results at conferences between 2021 and 2026. They plan to publish more results in the future.

Recruitment start: 1 May 2015

Recruitment end: 7 March 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor David Cunningham

Supported by

Clovis Oncology Inc

Eli Lilly and Company Limited

Experimental Cancer Medicine Centre (ECMC)

MedImmune LLC

National Institute of Health and Care Research (NIHR)

The Royal Marsden NHS Foundation Trust

The Royal Marsden Cancer Charity

Last reviewed: 28 Jul 2026

CRUK internal database number: 11683

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.